dr. graff on genomic risk prediction in hr /her2- breast cancer
Published 4 years ago • 364 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
0:52
dr. graff on future research with immunotherapy in breast cancer
-
1:18
dr. graff on extended adjuvant therapy in early-stage hr breast cancer
-
1:46
dr. graff on novel therapies in metastatic breast cancer
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
1:37
dr. meisel on optimizing genomic assays in early-stage hr-positive, her2-negative breast cancer
-
4:26
independent validation of the her2dx genomic test in her2-positive breast cancer
-
1:01
dr. stephanie graff - breast cancer risk
-
1:01
dr. graff on current treatments in esr1-mutant breast cancer
-
2:09
dr. wang on genomic analysis of breast cancer risk in pediatric cancer survivors
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:22
genomic profiling in her2 disease
-
7:11
genomic testing for risk of late recurrence/asco guidelines
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
0:35
dr. sledge on genomic sequencing in patients with breast cancer
-
1:28
dr. esteva on the clinical implications of genomic testing for breast cancer
-
0:55
dr. kropp on genomic signatures in breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:11
dr. hershman on misconceptions with the tailorx trial in hr /her2- breast cancer
-
7:02
genomic testing in breast cancer